Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Media S.A. 1079635 10.3389/fphar.2022.1079635 Pharmacology Correction Corrigendum: Controlling nutritional status (CONUT) predicts survival in gastric cancer patients with immune checkpoint inhibitor (PD-1/PD-L1) outcomes Chen et al. 10.3389/fphar.2022.1079635 Chen Li 1 2 ‡ † Sun Hao 2 ‡ Zhao Ruihu 2 Huang Rong 2 Pan Hongming 2 Zuo Yanjiao 2 Zhang Lele 2 Xue Yingwei 2 Song Hongjiang 2 * Li Xingrui 1 * 1 Department of Thyroid and Breast Surgery, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China 2 Department of Gastrointestinal Surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, China

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

 *Correspondence: Hongjiang Song, hongjiangsong2016@163.com; Xingrui Li, lixingrui@tjh.tjmu.edu.cn

ORCID: Li Chen, 0000-0002-6989-1177

These authors have contributed equally to this work

This article was submitted to Predictive Toxicology, a section of the journal Frontiers in Pharmacology

 14 11 2022 2022 13 1079635 25 10 2022 26 10 2022 Copyright © 2022 Chen, Sun, Zhao, Huang, Pan, Zuo, Zhang, Xue, Song and Li. 2022 Chen, Sun, Zhao, Huang, Pan, Zuo, Zhang, Xue, Song and Li

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Controlling nutritional status (CONUT) predicts survival ingastric cancer patients with immune checkpoint inhibitor (PD-1/PD-L1)outcomes by Chen L, Sun H, Zhao R, Huang R, Pan H, Zuo Y, Zhang L, Xue Y, Li X and Song H (2022). Front. Pharmacol. 13:836958. doi: 10.3389/fphar.2022.836958 gastric cancer controlling nutritional status immune checkpoint inhibitors PD-1 PD-L1

In the published article, there was an error in the Author list and Correspondence section, and authors Hongjiang Song and Xingrui Li were inserted in the wrong order. The corrected Author list and Correspondence section appear below.

“Li Chen, Hao Sun, Ruihu Zhao, Rong Huang, Hongming Pan, Yanjiao Zuo, Lele Zhang, Yingwei Xue, Hongjiang Song and Xingrui Li.”

“*Correspondence: Hongjiang Song, hongjiangsong2016@163.com; Xingrui Li, lixingrui@tjh.tjmu.edu.cn.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.